41 – 50 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
- Contribution to journal › Article
-
Mark
Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy : Retrospective multicenter study with different MRI scanners
- Contribution to journal › Article
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
- Contribution to journal › Article
-
Mark
Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer : A Prospective Analysis of the EPIC Study
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
- Contribution to journal › Article
-
Mark
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN study
- Contribution to journal › Article
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
(2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)
- Contribution to conference › Abstract
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
(2023) Acoustofluidics Conference 2023, St. Louis USA
- Contribution to conference › Abstract
-
Mark
Protein and amino acid intakes in relation to prostate cancer risk and mortality—A prospective study in the European Prospective Investigation into Cancer and Nutrition
- Contribution to journal › Article
-
Mark
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
- Contribution to journal › Article
